127 related articles for article (PubMed ID: 29049739)
1. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
Thariat J; Jacob S; Caujolle JP; Maschi C; Baillif S; Angellier G; Mathis T; Rosier L; Carnicer A; Hérault J; Salleron J
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5378-5386. PubMed ID: 29049739
[TBL] [Abstract][Full Text] [Related]
2. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
Mathis T; Rosier L; Meniai F; Baillif S; Maschi C; Herault J; Caujolle JP; Kodjikian L; Salleron J; Thariat J
Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
[TBL] [Abstract][Full Text] [Related]
3. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
4. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
5. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
[TBL] [Abstract][Full Text] [Related]
6. Lens changes after proton beam irradiation for uveal melanoma.
Gragoudas ES; Egan KM; Walsh SM; Regan S; Munzenrider JE; Taratuta V
Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
8. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
9. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.
Nguyen SM; Sison J; Jones M; Berry JL; Kim JW; Murphree AL; Salinas V; Olch AJ; Chang EL; Wong KK
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1143-1150. PubMed ID: 30537543
[TBL] [Abstract][Full Text] [Related]
10. Helium-ion-induced human cataractogenesis.
Blakely EA; Daftari IK; Meecham WJ; Alonso LC; Collier JM; Kroll SM; Gillette EL; Lee AC; Lett JT; Cox AB; Castro JR; Char DH
Adv Space Res; 1994 Oct; 14(10):501-5. PubMed ID: 11539986
[TBL] [Abstract][Full Text] [Related]
11. Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lee HJ; Stacey A; Klesert TR; Wells C; Skalet AH; Bloch C; Fung A; Bowen SR; Wong TP; Shibata D; Halasz LM; Rengan R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):374-382. PubMed ID: 30763658
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study.
Chino K; Tanyi JA; Stea B
Med Dosim; 2009; 34(1):57-62. PubMed ID: 19181257
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
Hartsell WF; Kapur R; Hartsell SO; Sweeney P; Lopes C; Duggal A; Cohen J; Chang J; Polasani RS; Dunn M; Pankuch M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):353-359. PubMed ID: 27084652
[TBL] [Abstract][Full Text] [Related]
14. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
15. Cataractogenesis after Cobalt-60 eye plaque radiotherapy.
Kleineidam M; Augsburger JJ; Hernandez C; Glennon P; Brady LW
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):625-30. PubMed ID: 8330992
[TBL] [Abstract][Full Text] [Related]
16. Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.
Gerard A; Peyrichon ML; Vidal M; Barnel C; Sauerwein W; Carnicer A; Angellier G; Mathis TM; Mishra KK; Thariat J; Herault J
Cancer Radiother; 2022 Nov; 26(8):1027-1033. PubMed ID: 35803862
[TBL] [Abstract][Full Text] [Related]
17. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
18. Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma.
Espensen CA; Kiilgaard JF; Appelt AL; Fog LS; Herault J; Maschi C; Caujolle JP; Thariat J
Ophthalmology; 2021 Jan; 128(1):152-161. PubMed ID: 32574763
[TBL] [Abstract][Full Text] [Related]
19. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
20. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]